Pharmaceutical

Health

AstraZeneca's Baxdrostat Achieves Major Success in Hypertension Trial

September 1, 2025 6:20am

AstraZeneca's Baxdrostat significantly reduces blood pressure in resistant hypertension patients, marking a key trial success.

Latest news

National September 8, 2025 3:37am

Concerns Rise Over PFAS Pesticide Use in Swedish Agriculture

Stockholm September 8, 2025 3:37am

Three Hospitalized After Kitchen Fire in Västertorp Apartment

Breaking September 8, 2025 3:37am

Rescue Operation Successfully Executes After Man Trapped in Limhamn Quarry

Breaking September 8, 2025 3:37am

Termination Circumstances Surround Double Murder Case in Klippan

Politics September 7, 2025 11:37pm

Jon Malmqvist Faces Trial After Traffic Incident

Politics September 7, 2025 11:37pm

Political Controversy Surrounds Sweden Democrats' Historical Ties to Racism